Press Releases

October 18, 2013 Lupin Receives International Sustainability Rating Standard (ISRS) Certification First Pharmaceutical Company globally to adopt ISRS, 8th Edition standard

October 3, 2013 Lupin launches Generic ZYMAXID™ Ophthalmic solution in the US

September 23, 2013 Lupin Expands US Pediatric Brands Portfolio Inks Strategic Agreement to Promote Locoid® Lotion to US Pediatricians

September 16, 2013 Lupin Receives FDA Approval for Generic Ambien CR® Extended-release Tablets

August 23, 2013 Lupin Receives FDA Approval for Generic Rifadin® Capsules

August 7, 2013 Lupin Expands Branded Play Announces Acquisition of Exclusive US Rights to Alinia® for Oral Suspension

August 7, 2013 Strong Margins, Robust Profitability Quarter I Results, FY 2013-14 EBITDA up 44%, Net profit up 43%

August 1, 2013 Lupin receives FDA Approval for Generic Ranexa® Extended-release Tablets

July 31, 2013 Lupin Receives Tentative FDA Approvals for Generic Nuvigil® Tablets and Generic Oracea® Capsules